Paired Basic Amino Acid-cleaving Enzyme 4 (PCSK6): An Emerging New Target Molecule in Human Melanoma

Area of Science:

• Oncology
• Molecular Biology
• Biochemistry

Background:

• Melanoma necessitates novel therapeutic targets despite recent advancements.
• Prohormone convertases are implicated in tumor progression by processing key molecules like growth factors and matrix-metalloproteinases.

Purpose of the Study:

• To investigate the role of prohormone convertase Paired basic Amino acid-Cleaving Enzyme 4 (PACE4/PCSK6) in melanoma.
• To identify PACE4 as a potential therapeutic target for melanoma treatment.

Main Methods:

• PACE4 expression and function were assessed in A375 melanoma cell lines.
• In vitro assays measured proliferation, MMP-2 production, gelatinase activity, and migration.
• In vivo studies utilized immunodeficient mice to evaluate tumor growth.
• PACE4 immunoreactivity was examined in human primary melanomas and metastases.

Main Results:

• PACE4-transfected melanoma cells exhibited increased proliferation, MMP-2 production, gelatinase activity, and migration in vitro.
• Elevated PACE4 expression significantly enhanced tumor growth in vivo.
• PACE4 immunoreactivity was detected in most human melanoma tissues but not in situ melanomas.

Conclusions:

• PACE4 acts as a regulator of melanoma cell aggressiveness.
• PACE4 is a promising therapeutic target for melanoma treatment.